07/31/17  Portland, Ore.

Novel pre-clinical study of radiotherapy-guided delivery of anti-MGMT morpholinos oligonucleotides may increase therapeutic ratio in non-methylated solid tumors [PDF], was published in Cancer Gene Therapy[NCBI] . Joshua Walker, MD, PhD, is a co-author on this collaborative original research with our neuro-oncology research colleagues.